Loefflers syndrome primary prevention: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 3: Line 3:
{{CMG}}
{{CMG}}
==Overview==
==Overview==
There are no established measures for the primary prevention of [disease name].
There are no established measures for the primary prevention of Löffler syndrome.


OR
OR


There are no available vaccines against [disease name].
There are no available vaccines against Löffler syndrome.


OR
OR


Effective measures for the primary prevention of [disease name] include [measure1], [measure2], and [measure3].
Effective measures for the primary prevention of Löffler syndrome include [measure1], [measure2], and [measure3].


OR
OR


[Vaccine name] vaccine is recommended for [patient population] to prevent [disease name]. Other primary prevention strategies include [strategy 1], [strategy 2], and [strategy 3].
[Vaccine name] vaccine is recommended for [patient population] to prevent Löffler syndrome. Other primary prevention strategies include [strategy 1], [strategy 2], and [strategy 3].


==Primary Prevention==
==Primary Prevention==
There are no established measures for the primary prevention of [disease name].
There are no established measures for the primary prevention of Löffler syndrome.


OR
OR


There are no available vaccines against [disease name].
There are no available vaccines against Löffler syndrome.


OR
OR


Effective measures for the primary prevention of [disease name] include:
Effective measures for the primary prevention of Löffler syndrome include:
*[Measure1]
*[Measure1]
*[Measure2]
*[Measure2]
Line 33: Line 33:
OR
OR


[Vaccine name] vaccine is recommended for [patient population] to prevent [disease name]. Other primary prevention strategies include:
[Vaccine name] vaccine is recommended for [patient population] to prevent Löffler syndrome. Other primary prevention strategies include:
*[Strategy 1]
*[Strategy 1]
*[Strategy 2]
*[Strategy 2]
Line 44: Line 44:
{{WH}}
{{WH}}
{{WS}}
{{WS}}


[[Category:Pulmonology]]
[[Category:Pulmonology]]

Revision as of 18:37, 6 June 2019

Löffler's syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Loefflers syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Loefflers syndrome primary prevention On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Loefflers syndrome primary prevention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Loefflers syndrome primary prevention

CDC on Loefflers syndrome primary prevention

Loefflers syndrome primary prevention in the news

Blogs on Loefflers syndrome primary prevention

Directions to Hospitals Treating Loefflers syndrome

Risk calculators and risk factors for Loefflers syndrome primary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

There are no established measures for the primary prevention of Löffler syndrome.

OR

There are no available vaccines against Löffler syndrome.

OR

Effective measures for the primary prevention of Löffler syndrome include [measure1], [measure2], and [measure3].

OR

[Vaccine name] vaccine is recommended for [patient population] to prevent Löffler syndrome. Other primary prevention strategies include [strategy 1], [strategy 2], and [strategy 3].

Primary Prevention

There are no established measures for the primary prevention of Löffler syndrome.

OR

There are no available vaccines against Löffler syndrome.

OR

Effective measures for the primary prevention of Löffler syndrome include:

  • [Measure1]
  • [Measure2]
  • [Measure3]

OR

[Vaccine name] vaccine is recommended for [patient population] to prevent Löffler syndrome. Other primary prevention strategies include:

  • [Strategy 1]
  • [Strategy 2]
  • [Strategy 3]

Primary Preventiion

This is a rare disorder. Many times, the cause cannot be found. Minimizing exposure to possible risk factors (certain medicines, some metals) may reduce risk.

References

Template:WH Template:WS